K. d'Hollander

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

L Biganzoli, F Puglisi, M Buyse, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Momelotinib reduces transfusion requirements in patients with myelofibrosis

S. Verstovsek, R. Donahue, R. Mesa, 2022, Leukemia & lymphoma.

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

S. Sleijfer, L. Esserman, B. Naume, 2018, Journal of the National Cancer Institute.

The case against censoring of progression-free survival in cancer clinical trials – A pandemic shutdown as an illustration

L. Collette, E. Saad, T. Burzykowski, 2021, BMC Medical Research Methodology.

Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.

C. O. Kamlin, D. Cassiman, A. Poujois, 2022, The lancet. Gastroenterology & hepatology.